WIN-Partners Co., Ltd. engages in the management of its group of companies that sell medical devices. Its products are used for angina or myocardial infarction, irregular pulse, aortic aneurysm, arteriosclerosis obliterans, cerebral aneurysm, and diabetes. The company was founded on April 1, 2013 and is headquartered in Tokyo, Japan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company